4//SEC Filing
Arnold Matthew Bennett 4
Accession 0000899243-19-001270
CIK 0001707502other
Filed
Jan 15, 7:00 PM ET
Accepted
Jan 16, 1:07 PM ET
Size
7.4 KB
Accession
0000899243-19-001270
Insider Transaction Report
Form 4
Arnold Matthew Bennett
Director
Transactions
- Sale
Common Stock
2019-01-14$32.20/sh−3,300$106,258→ 3,386,293 total - Sale
Common Stock
2019-01-14$31.60/sh−1,700$53,724→ 3,389,593 total
Footnotes (3)
- [F1]The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 5, 2018.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.05 to $32.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.75, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form.
Documents
Issuer
Solid Biosciences Inc.
CIK 0001707502
Entity typeother
Related Parties
1- filerCIK 0001727991
Filing Metadata
- Form type
- 4
- Filed
- Jan 15, 7:00 PM ET
- Accepted
- Jan 16, 1:07 PM ET
- Size
- 7.4 KB